Claire Wainwright

Summary

Country: Australia

Publications

  1. pmc A comparison of two informative SNP-based strategies for typing Pseudomonas aeruginosa isolates from patients with cystic fibrosis
    Melanie W Syrmis
    Queensland Children s Medical Research Institute, The University of Queensland, Brisbane, Queensland 4029, Australia
    BMC Infect Dis 14:307. 2014
  2. doi request reprint Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial
    Claire E Wainwright
    Queensland Children s Medical Research Institute, and Queensland Children s Respiratory Centre, Royal Children s Hospital, University of Queensland, Brisbane, Australia
    JAMA 306:163-71. 2011
  3. doi request reprint Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosa
    C E Wainwright
    Queensland Children s Respiratory Centre, Royal Children s Hospital, Herston Rd Herston, Queensland 4029, Australia
    J Cyst Fibros 10:234-42. 2011
  4. doi request reprint Acute viral bronchiolitis in children- a very common condition with few therapeutic options
    Claire Wainwright
    Department of Paediatrics and Child Health, Queensland Children s Respiratory Centre, Royal Children s Hospital, University of Queensland, Herston Rd, Herston, Queensland, Australia 4029
    Paediatr Respir Rev 11:39-45; quiz 45. 2010
  5. pmc Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis
    C E Wainwright
    Department of Respiratory Medicine, Royal Children s Hospital and Health Service District, Brisbane, Australia
    Thorax 64:926-31. 2009
  6. doi request reprint Safety of bronchoalveolar lavage in young children with cystic fibrosis
    Claire E Wainwright
    Department of Respiratory Medicine, Royal Children s Hospital, Brisbane, Australia
    Pediatr Pulmonol 43:965-72. 2008
  7. ncbi request reprint A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis
    Claire Wainwright
    Department of Respiratory Medicine, Royal Children s Hospital, Brisbane, Queensland, Australia
    N Engl J Med 349:27-35. 2003
  8. ncbi request reprint A clinical pathway for bronchiolitis is effective in reducing readmission rates
    Joyce Cheney
    Department of Respiratory Medicine, Royal Children s Hospital, The School of Nursing, Queensland University of Technology, Australia
    J Pediatr 147:622-6. 2005
  9. ncbi request reprint Quality-of-life in children and adolescents with cystic fibrosis managed in both regional outreach and cystic fibrosis center settings in Queensland
    Clare Thomas
    Royal Children s Hospital, and the School of Population Health, University of Queensland, Brisbane, Queensland, Australia
    J Pediatr 148:508-516. 2006
  10. ncbi request reprint Fosfomycin--investigation of a possible new route of administration of an old drug. A case study
    Michele Cree
    Pharmacy Department, Royal Children s Hospital, Brisbane, Australia
    J Cyst Fibros 6:244-6. 2007

Collaborators

Detail Information

Publications15

  1. pmc A comparison of two informative SNP-based strategies for typing Pseudomonas aeruginosa isolates from patients with cystic fibrosis
    Melanie W Syrmis
    Queensland Children s Medical Research Institute, The University of Queensland, Brisbane, Queensland 4029, Australia
    BMC Infect Dis 14:307. 2014
    ..aeruginosa SNPs and using real-time polymerase chain reaction technology (HRM10SNP) and the other targeting 20 SNPs and based on the Sequenom MassARRAY platform (iPLEX20SNP)...
  2. doi request reprint Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial
    Claire E Wainwright
    Queensland Children s Medical Research Institute, and Queensland Children s Respiratory Centre, Royal Children s Hospital, University of Queensland, Brisbane, Australia
    JAMA 306:163-71. 2011
    ..While bronchoalveolar lavage (BAL) is an alternative diagnostic tool, evidence for its clinical benefit is lacking...
  3. doi request reprint Aztreonam for inhalation solution (AZLI) in patients with cystic fibrosis, mild lung impairment, and P. aeruginosa
    C E Wainwright
    Queensland Children s Respiratory Centre, Royal Children s Hospital, Herston Rd Herston, Queensland 4029, Australia
    J Cyst Fibros 10:234-42. 2011
    ..This double-blind, multicenter, randomized, placebo-controlled trial enrolled patients (≥6 years) with FEV(1)>75% predicted...
  4. doi request reprint Acute viral bronchiolitis in children- a very common condition with few therapeutic options
    Claire Wainwright
    Department of Paediatrics and Child Health, Queensland Children s Respiratory Centre, Royal Children s Hospital, University of Queensland, Herston Rd, Herston, Queensland, Australia 4029
    Paediatr Respir Rev 11:39-45; quiz 45. 2010
    ....
  5. pmc Cough-generated aerosols of Pseudomonas aeruginosa and other Gram-negative bacteria from patients with cystic fibrosis
    C E Wainwright
    Department of Respiratory Medicine, Royal Children s Hospital and Health Service District, Brisbane, Australia
    Thorax 64:926-31. 2009
    ..It was hypothesised that subjects with CF produce viable respirable bacterial aerosols with coughing...
  6. doi request reprint Safety of bronchoalveolar lavage in young children with cystic fibrosis
    Claire E Wainwright
    Department of Respiratory Medicine, Royal Children s Hospital, Brisbane, Australia
    Pediatr Pulmonol 43:965-72. 2008
    ..Our aim was to determine the safety of BAL in young children <6 years with CF...
  7. ncbi request reprint A multicenter, randomized, double-blind, controlled trial of nebulized epinephrine in infants with acute bronchiolitis
    Claire Wainwright
    Department of Respiratory Medicine, Royal Children s Hospital, Brisbane, Queensland, Australia
    N Engl J Med 349:27-35. 2003
    ..The role of bronchodilators is controversial. Most studies of the use of bronchodilators have enrolled small numbers of subjects and have examined only short-term outcomes, such as clinical scores...
  8. ncbi request reprint A clinical pathway for bronchiolitis is effective in reducing readmission rates
    Joyce Cheney
    Department of Respiratory Medicine, Royal Children s Hospital, The School of Nursing, Queensland University of Technology, Australia
    J Pediatr 147:622-6. 2005
    ..To examine the use of a clinical pathway in the management of infants hospitalized with acute viral bronchiolitis...
  9. ncbi request reprint Quality-of-life in children and adolescents with cystic fibrosis managed in both regional outreach and cystic fibrosis center settings in Queensland
    Clare Thomas
    Royal Children s Hospital, and the School of Population Health, University of Queensland, Brisbane, Queensland, Australia
    J Pediatr 148:508-516. 2006
    ..To compare HRQOL of children with CF in Queensland with previously published HRQOL data from the United States and examine the relationship between HRQOL scores and pulmonary function...
  10. ncbi request reprint Fosfomycin--investigation of a possible new route of administration of an old drug. A case study
    Michele Cree
    Pharmacy Department, Royal Children s Hospital, Brisbane, Australia
    J Cyst Fibros 6:244-6. 2007
    ..This case discusses the successful use of fosfomycin via the subcutaneous route in a paediatric patient with cystic fibrosis...
  11. doi request reprint What does advanced practice mean to Australian paediatric pharmacists? A focus group study
    Sonya R Stacey
    Queensland Children s Medical Research Institute, The University of Queensland, Brisbane, QLD, Australia School of Pharmacy, The University of Queensland, Brisbane, QLD, Australia Royal Children s Hospital, Children s Health Queensland Hospital and Health Service, Brisbane, QLD, Australia
    Int J Pharm Pract 23:141-9. 2015
    ..The aim of this study was to explore perceptions and attitudes of Australian paediatric pharmacists about advanced pharmacy practice and to identify suitable methods of assessment for this level of practice...
  12. pmc Early airway infection, inflammation, and lung function in cystic fibrosis
    G M Nixon
    Department of Respiratory Medicine, Royal Children s Hospital, Melbourne, Australia
    Arch Dis Child 87:306-11. 2002
    ..To determine the relation between lower airway infection and inflammation, respiratory symptoms, and lung function in infants and young children with cystic fibrosis (CF)...
  13. ncbi request reprint Infants with chronic neonatal lung disease: recommendations for the use of home oxygen therapy
    Dominic A Fitzgerald
    Department of Respiratory Medicine, The Children s Hospital at Westmead, Sydney, NSW, Australia
    Med J Aust 189:578-82. 2008
    ..Discontinuation of oxygen therapy is based on clinical assessments and documentation of adequate oxygenation in room air. There is limited objective evidence on which to base recommendations...
  14. ncbi request reprint Misleading high tobramycin plasma concentrations can be caused by skin contamination of fingerprick blood following inhalation of nebulized tobramycin (TOBI): a short report
    Stefanie Redmann
    School of Pharmacy, The University of Queensland, Brisbane, Queensland 4072, Australia
    Ther Drug Monit 27:205-7. 2005
    ..We caution that therapeutic drug monitoring of nebulized tobramycin should not be done by fingerprick sampling, and care should be taken to avoid contamination of the venipuncture site...
  15. doi request reprint Characteristics of adverse medication events in a children's hospital
    Sonya Stacey
    Queensland Children s Medical Research Institute, The University of Queensland, Brisbane, Queensland, Australia School of Pharmacy, The University of Queensland, Brisbane, Queensland, Australia Royal Children s Hospital, Children s Health Queensland Hospital and Health Service, Brisbane, Queensland, Australia
    J Paediatr Child Health 50:966-71. 2014
    ..To compare adverse medication events (AMEs) reported in children, via the International Statistical Classification of Diseases and Related Health Problems 10th Revision (ICD-10) coding with events reported via other data sources...